Coherus Oncology is a startup based in the United States, 1 tracked investor.
Coherus Oncology is a startup based in the United States. Brouky records 1 investor associated with the company.
Coherus Oncology develops next-generation combination immuno-oncology therapies targeting the tumor microenvironment to treat various cancers, including FDA-approved treatments for nasopharyngeal carcinoma.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.